Skip to main content
Caplight Logo









AfaSci, Inc.

AfaSci, Inc.

Private
Burlingame, CaliforniaHealthcare & Life Scienceshttps://afasci.com/

Total Funding Raised

$5.2M

Company Overview

AfaSci, Inc. is a biopharmaceutical company that discovers and develops peptide and small molecule therapies for neurological disorders, while also providing contract research services and commercializing rodent behavioral monitoring instruments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

small molecule therapeuticsCNS disordersnon-opioid analgesicspreclinical contract researchrodent behavioral monitoringelectrophysiology servicespharmacokinetic testingPK/PD testingin vivo pharmacologyCROlab automationdrug discovery toolsphenotypic screeningbiotech equipmentpain management research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AfaSci, Inc. Comparables

Compare AfaSci, Inc. with similar companies based on industry and business-model similarity.

AfaSci, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EicOsis Human Health, Inc.
76%
Harvard Bioscience
69%
Clever Sys, Inc.
64%

AfaSci, Inc. Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Key People

Founding team and executive leadership

Xinmin Simon Xie

President and Chief Executive Officer

Executive Team

Sue Li

CFO

Executive Team

AfaSci, Inc. Investors

Notable investors and investment history

AfaSci, Inc. investors
InvestorRounds
NIH RADxGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 85% MoM.

  • Jan 20, 2026

    Monthly visitors increased 154% MoM.

AfaSci, Inc. Filings

Explore SEC and related filing metadata, where available.

AfaSci, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AfaSci, Inc.'s valuation, stock price, and market status.

Is AfaSci, Inc. a public or private company?

AfaSci, Inc. is a private company.

What is the current stock price of AfaSci, Inc.?

AfaSci, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is AfaSci, Inc. worth (valuation)?

Valuation information for AfaSci, Inc. is not publicly available.

Can I buy AfaSci, Inc. stock?

AfaSci, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AfaSci, Inc.'s last funding round?

Funding round information for AfaSci, Inc. is not publicly available.

Who are the main investors in AfaSci, Inc.?

Key investors in AfaSci, Inc. include NIH RADx.

Will AfaSci, Inc. IPO soon?

No public IPO plans have been announced for AfaSci, Inc..

How can I track AfaSci, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AfaSci, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBurlingame, California
Employee Range16
Year Founded2003
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?